Preparing patients for life after bariatric surgery

Article Type
Changed
Display Headline
Preparing patients for life after bariatric surgery

With obesity on the rise, more people are seeking alternatives to failed diets, grueling exercise regimens, and prescription weight-loss agents with troublesome side effects.

Bariatric surgery offers hope to morbidly obese persons (defined as having a body mass index [BMI] 40 kg/m2) and to those with a BMI >34 kg/m2 who suffer hypertension, diabetes, and other comorbidities. The procedure produces significant short-term gains (diminished binge eating, weight loss, alleviation of depressed mood) and long-term benefits (improved self-image; increased HDL; lower apoprotein beta-containing lipoproteins; and lower LDL, blood pressure, and fasting blood glucose).

Too often, however, patients see bariatric surgery as a quick fix. Although hunger and stomach capacity are reduced, some patients do eat compulsively,1 and many regain weight after surgery. Patients also may not realize that they must make extensive lifestyle changes and adjust psychologically to life as a normal-weight person.

Suicide is a major cause of postoperative death, either because of poor psychosocial adjustment or the emergence of an occult personality disorder. Continued alcohol consumption and noncompliance with prescribed vitamin or mineral regimens can also be fatal.

Gauging patient readiness

A preoperative psychiatric evaluation can uncover mental disorders and other risk factors for postoperative noncompliance. Evaluate the following issues:

 

  • What caused or contributed to the patient’s obesity? Bariatric surgery candidates have a high prevalence of psychopathology, including major depression, binge eating, and personality disorders.2,3 Untreated depression, bulimia, suicidality, and substance abuse are contraindications to bariatric surgery. Pre-existing major depression and binge-eating disorder are not, however.
  • How does the patient perceive his or her body? Patients who have unrealistic perceptions about their bodies, such as those with eating disorders or psychoses, are poor surgical candidates. Such patients are unlikely to be satisfied with their postoperative body size.
  • Why has the patient chosen to undergo bariatric surgery at this time? Ask whether he or she views it as a major procedure, and determine his or her level of conviction about receiving the surgery.
  • Can the patient expect support from family and friends? Undue pressure from family members, such as a significant other’s dissatisfaction with the patient’s pre-operative body size, may lead to postoperative psychosocial maladjustment. A collateral history may be useful.
  • Is the patient aware that postoperative behavioral changes will be needed? People will treat the patient differently and may even comment frequently about his or her new body size. Moreover, instead of eating as a coping mechanism, patients will need to find other ways to deal with unpleasant emotions.
  • Does the patient understand the postoperative requirements? Reiterate that the patient must participate in group psychotherapy and follow postoperative instructions. The patient’s history of dieting, exercise, and weight-loss prescriptions may offer clues to prospective post-op compliance. Patients who have not complied with less invasive measures are not likely to be compliant after bariatric surgery.

Finally, to prevent miscommunication between patient and provider, ask the surgeon what he or she has told the patient about the procedure. A Minnesota Multiphasic Personality Inventory test can help confirm psychiatric diagnoses and determine whether the patient is being candid.

References

 

1. Saunders R. Compulsive eating and gastric bypass surgery: what does hunger have to do with it? Obes Surg 2001;11(6):757-61.

2. Wadden TA, Sarwer DB, Womble LG, et al. Psychosocial aspects of obesity and obesity surgery. Surg Clin North Am 2001;81(5):1001-24.

3. Glinski J, et al. The psychology of gastric bypass surgery. Obes Surg 2001;11:581-8.

Dr. Menaster practices psychiatry in San Francisco, CA

Article PDF
Author and Disclosure Information

 

Michael Menaster, MD, on

Issue
Current Psychiatry - 02(01)
Publications
Topics
Page Number
70-70
Sections
Author and Disclosure Information

 

Michael Menaster, MD, on

Author and Disclosure Information

 

Michael Menaster, MD, on

Article PDF
Article PDF

With obesity on the rise, more people are seeking alternatives to failed diets, grueling exercise regimens, and prescription weight-loss agents with troublesome side effects.

Bariatric surgery offers hope to morbidly obese persons (defined as having a body mass index [BMI] 40 kg/m2) and to those with a BMI >34 kg/m2 who suffer hypertension, diabetes, and other comorbidities. The procedure produces significant short-term gains (diminished binge eating, weight loss, alleviation of depressed mood) and long-term benefits (improved self-image; increased HDL; lower apoprotein beta-containing lipoproteins; and lower LDL, blood pressure, and fasting blood glucose).

Too often, however, patients see bariatric surgery as a quick fix. Although hunger and stomach capacity are reduced, some patients do eat compulsively,1 and many regain weight after surgery. Patients also may not realize that they must make extensive lifestyle changes and adjust psychologically to life as a normal-weight person.

Suicide is a major cause of postoperative death, either because of poor psychosocial adjustment or the emergence of an occult personality disorder. Continued alcohol consumption and noncompliance with prescribed vitamin or mineral regimens can also be fatal.

Gauging patient readiness

A preoperative psychiatric evaluation can uncover mental disorders and other risk factors for postoperative noncompliance. Evaluate the following issues:

 

  • What caused or contributed to the patient’s obesity? Bariatric surgery candidates have a high prevalence of psychopathology, including major depression, binge eating, and personality disorders.2,3 Untreated depression, bulimia, suicidality, and substance abuse are contraindications to bariatric surgery. Pre-existing major depression and binge-eating disorder are not, however.
  • How does the patient perceive his or her body? Patients who have unrealistic perceptions about their bodies, such as those with eating disorders or psychoses, are poor surgical candidates. Such patients are unlikely to be satisfied with their postoperative body size.
  • Why has the patient chosen to undergo bariatric surgery at this time? Ask whether he or she views it as a major procedure, and determine his or her level of conviction about receiving the surgery.
  • Can the patient expect support from family and friends? Undue pressure from family members, such as a significant other’s dissatisfaction with the patient’s pre-operative body size, may lead to postoperative psychosocial maladjustment. A collateral history may be useful.
  • Is the patient aware that postoperative behavioral changes will be needed? People will treat the patient differently and may even comment frequently about his or her new body size. Moreover, instead of eating as a coping mechanism, patients will need to find other ways to deal with unpleasant emotions.
  • Does the patient understand the postoperative requirements? Reiterate that the patient must participate in group psychotherapy and follow postoperative instructions. The patient’s history of dieting, exercise, and weight-loss prescriptions may offer clues to prospective post-op compliance. Patients who have not complied with less invasive measures are not likely to be compliant after bariatric surgery.

Finally, to prevent miscommunication between patient and provider, ask the surgeon what he or she has told the patient about the procedure. A Minnesota Multiphasic Personality Inventory test can help confirm psychiatric diagnoses and determine whether the patient is being candid.

With obesity on the rise, more people are seeking alternatives to failed diets, grueling exercise regimens, and prescription weight-loss agents with troublesome side effects.

Bariatric surgery offers hope to morbidly obese persons (defined as having a body mass index [BMI] 40 kg/m2) and to those with a BMI >34 kg/m2 who suffer hypertension, diabetes, and other comorbidities. The procedure produces significant short-term gains (diminished binge eating, weight loss, alleviation of depressed mood) and long-term benefits (improved self-image; increased HDL; lower apoprotein beta-containing lipoproteins; and lower LDL, blood pressure, and fasting blood glucose).

Too often, however, patients see bariatric surgery as a quick fix. Although hunger and stomach capacity are reduced, some patients do eat compulsively,1 and many regain weight after surgery. Patients also may not realize that they must make extensive lifestyle changes and adjust psychologically to life as a normal-weight person.

Suicide is a major cause of postoperative death, either because of poor psychosocial adjustment or the emergence of an occult personality disorder. Continued alcohol consumption and noncompliance with prescribed vitamin or mineral regimens can also be fatal.

Gauging patient readiness

A preoperative psychiatric evaluation can uncover mental disorders and other risk factors for postoperative noncompliance. Evaluate the following issues:

 

  • What caused or contributed to the patient’s obesity? Bariatric surgery candidates have a high prevalence of psychopathology, including major depression, binge eating, and personality disorders.2,3 Untreated depression, bulimia, suicidality, and substance abuse are contraindications to bariatric surgery. Pre-existing major depression and binge-eating disorder are not, however.
  • How does the patient perceive his or her body? Patients who have unrealistic perceptions about their bodies, such as those with eating disorders or psychoses, are poor surgical candidates. Such patients are unlikely to be satisfied with their postoperative body size.
  • Why has the patient chosen to undergo bariatric surgery at this time? Ask whether he or she views it as a major procedure, and determine his or her level of conviction about receiving the surgery.
  • Can the patient expect support from family and friends? Undue pressure from family members, such as a significant other’s dissatisfaction with the patient’s pre-operative body size, may lead to postoperative psychosocial maladjustment. A collateral history may be useful.
  • Is the patient aware that postoperative behavioral changes will be needed? People will treat the patient differently and may even comment frequently about his or her new body size. Moreover, instead of eating as a coping mechanism, patients will need to find other ways to deal with unpleasant emotions.
  • Does the patient understand the postoperative requirements? Reiterate that the patient must participate in group psychotherapy and follow postoperative instructions. The patient’s history of dieting, exercise, and weight-loss prescriptions may offer clues to prospective post-op compliance. Patients who have not complied with less invasive measures are not likely to be compliant after bariatric surgery.

Finally, to prevent miscommunication between patient and provider, ask the surgeon what he or she has told the patient about the procedure. A Minnesota Multiphasic Personality Inventory test can help confirm psychiatric diagnoses and determine whether the patient is being candid.

References

 

1. Saunders R. Compulsive eating and gastric bypass surgery: what does hunger have to do with it? Obes Surg 2001;11(6):757-61.

2. Wadden TA, Sarwer DB, Womble LG, et al. Psychosocial aspects of obesity and obesity surgery. Surg Clin North Am 2001;81(5):1001-24.

3. Glinski J, et al. The psychology of gastric bypass surgery. Obes Surg 2001;11:581-8.

Dr. Menaster practices psychiatry in San Francisco, CA

References

 

1. Saunders R. Compulsive eating and gastric bypass surgery: what does hunger have to do with it? Obes Surg 2001;11(6):757-61.

2. Wadden TA, Sarwer DB, Womble LG, et al. Psychosocial aspects of obesity and obesity surgery. Surg Clin North Am 2001;81(5):1001-24.

3. Glinski J, et al. The psychology of gastric bypass surgery. Obes Surg 2001;11:581-8.

Dr. Menaster practices psychiatry in San Francisco, CA

Issue
Current Psychiatry - 02(01)
Issue
Current Psychiatry - 02(01)
Page Number
70-70
Page Number
70-70
Publications
Publications
Topics
Article Type
Display Headline
Preparing patients for life after bariatric surgery
Display Headline
Preparing patients for life after bariatric surgery
Sections
Disallow All Ads
Article PDF Media

HIV update 2002: Delaying treatment to curb rising resistance

Article Type
Changed
Display Headline
HIV update 2002: Delaying treatment to curb rising resistance
Article PDF
Author and Disclosure Information

Wendy Armstrong, MD
Department of Infectious Disease, The Cleveland Clinic

Leonard Calabrese, DO
Section Head, Clinical Immunology, Department of Rheumatic and Immunologic Disease, The Cleveland Clinic

Alan Taege, MD
Department of Infectious Disease, The Cleveland Clinic

Address: Wendy Armstrong, MD, Department of Infectious Disease, S32, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: armstrw@ccf.org

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the authors but are not peer-reviewed.

This paper discusses treatments that are not approved by the US Food and Drug Administration for the use under discussion.

Issue
Cleveland Clinic Journal of Medicine - 69(12)
Publications
Topics
Page Number
995-999
Sections
Author and Disclosure Information

Wendy Armstrong, MD
Department of Infectious Disease, The Cleveland Clinic

Leonard Calabrese, DO
Section Head, Clinical Immunology, Department of Rheumatic and Immunologic Disease, The Cleveland Clinic

Alan Taege, MD
Department of Infectious Disease, The Cleveland Clinic

Address: Wendy Armstrong, MD, Department of Infectious Disease, S32, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: armstrw@ccf.org

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the authors but are not peer-reviewed.

This paper discusses treatments that are not approved by the US Food and Drug Administration for the use under discussion.

Author and Disclosure Information

Wendy Armstrong, MD
Department of Infectious Disease, The Cleveland Clinic

Leonard Calabrese, DO
Section Head, Clinical Immunology, Department of Rheumatic and Immunologic Disease, The Cleveland Clinic

Alan Taege, MD
Department of Infectious Disease, The Cleveland Clinic

Address: Wendy Armstrong, MD, Department of Infectious Disease, S32, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: armstrw@ccf.org

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the authors but are not peer-reviewed.

This paper discusses treatments that are not approved by the US Food and Drug Administration for the use under discussion.

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 69(12)
Issue
Cleveland Clinic Journal of Medicine - 69(12)
Page Number
995-999
Page Number
995-999
Publications
Publications
Topics
Article Type
Display Headline
HIV update 2002: Delaying treatment to curb rising resistance
Display Headline
HIV update 2002: Delaying treatment to curb rising resistance
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Gallbladder disease: An update on diagnosis and treatment

Article Type
Changed
Display Headline
Gallbladder disease: An update on diagnosis and treatment
Article PDF
Author and Disclosure Information

David P. Vogt, MD
General and Liver Transplant Surgery, Transplant Center, and Department of General Surgery, The Cleveland Clinic  

Address: David P. Vogt, MD, Department of General Surgery, A110, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail vogtd@ccf.org

Issue
Cleveland Clinic Journal of Medicine - 69(12)
Publications
Topics
Page Number
977-984
Sections
Author and Disclosure Information

David P. Vogt, MD
General and Liver Transplant Surgery, Transplant Center, and Department of General Surgery, The Cleveland Clinic  

Address: David P. Vogt, MD, Department of General Surgery, A110, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail vogtd@ccf.org

Author and Disclosure Information

David P. Vogt, MD
General and Liver Transplant Surgery, Transplant Center, and Department of General Surgery, The Cleveland Clinic  

Address: David P. Vogt, MD, Department of General Surgery, A110, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail vogtd@ccf.org

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 69(12)
Issue
Cleveland Clinic Journal of Medicine - 69(12)
Page Number
977-984
Page Number
977-984
Publications
Publications
Topics
Article Type
Display Headline
Gallbladder disease: An update on diagnosis and treatment
Display Headline
Gallbladder disease: An update on diagnosis and treatment
Sections
Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Risedronate prevents hip fractures, but who should get therapy?

Article Type
Changed
Display Headline
Risedronate prevents hip fractures, but who should get therapy?
The HIP trial
Article PDF
Author and Disclosure Information

Chad L. Deal, MD
Head, Center for Osteoporosis and Metabolic Bone Disease, Department of Rheumatic and Immunologic Diseases, The Cleveland Clinic

Address: Chad L. Deal, MD, Head, Center for Osteoporosis and Metabolic Bone Disease, Department of Rheumatic and Immunologic Diseases, A50, The Cleveland Clinic Foundation,9500 Euclid Avenue, Cleveland, OH 44195

Issue
Cleveland Clinic Journal of Medicine - 69(12)
Publications
Topics
Page Number
964, 968-970, 973-976
Sections
Author and Disclosure Information

Chad L. Deal, MD
Head, Center for Osteoporosis and Metabolic Bone Disease, Department of Rheumatic and Immunologic Diseases, The Cleveland Clinic

Address: Chad L. Deal, MD, Head, Center for Osteoporosis and Metabolic Bone Disease, Department of Rheumatic and Immunologic Diseases, A50, The Cleveland Clinic Foundation,9500 Euclid Avenue, Cleveland, OH 44195

Author and Disclosure Information

Chad L. Deal, MD
Head, Center for Osteoporosis and Metabolic Bone Disease, Department of Rheumatic and Immunologic Diseases, The Cleveland Clinic

Address: Chad L. Deal, MD, Head, Center for Osteoporosis and Metabolic Bone Disease, Department of Rheumatic and Immunologic Diseases, A50, The Cleveland Clinic Foundation,9500 Euclid Avenue, Cleveland, OH 44195

Article PDF
Article PDF
The HIP trial
The HIP trial
Issue
Cleveland Clinic Journal of Medicine - 69(12)
Issue
Cleveland Clinic Journal of Medicine - 69(12)
Page Number
964, 968-970, 973-976
Page Number
964, 968-970, 973-976
Publications
Publications
Topics
Article Type
Display Headline
Risedronate prevents hip fractures, but who should get therapy?
Display Headline
Risedronate prevents hip fractures, but who should get therapy?
Sections
Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Emphysema in nonsmokers: Alpha 1-antitrypsin deficiency and other causes

Article Type
Changed
Display Headline
Emphysema in nonsmokers: Alpha 1-antitrypsin deficiency and other causes
Article PDF
Author and Disclosure Information

Pyng Lee, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

Thomas R. Gildea, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

James K. Stoller, MD, MS
Vice Chairman, Division of Medicine; Head, Section of Respiratory Therapy, Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic 

Address: James K. Stoller, MD, Department of Pulmonary and Critical Care Medicine, A90, The Cleveland Clinic Foundation, 9500 Euclid Avenue,Cleveland, OH 44195

Dr. Stoller has indicated that he has received grant or research support from Alpha Therapeutics and that he is a consultant for Baxter Healthcare Corporation.

Issue
Cleveland Clinic Journal of Medicine - 69(12)
Publications
Topics
Page Number
928-929, 933, 936, 939, 943-946
Sections
Author and Disclosure Information

Pyng Lee, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

Thomas R. Gildea, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

James K. Stoller, MD, MS
Vice Chairman, Division of Medicine; Head, Section of Respiratory Therapy, Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic 

Address: James K. Stoller, MD, Department of Pulmonary and Critical Care Medicine, A90, The Cleveland Clinic Foundation, 9500 Euclid Avenue,Cleveland, OH 44195

Dr. Stoller has indicated that he has received grant or research support from Alpha Therapeutics and that he is a consultant for Baxter Healthcare Corporation.

Author and Disclosure Information

Pyng Lee, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

Thomas R. Gildea, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

James K. Stoller, MD, MS
Vice Chairman, Division of Medicine; Head, Section of Respiratory Therapy, Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic 

Address: James K. Stoller, MD, Department of Pulmonary and Critical Care Medicine, A90, The Cleveland Clinic Foundation, 9500 Euclid Avenue,Cleveland, OH 44195

Dr. Stoller has indicated that he has received grant or research support from Alpha Therapeutics and that he is a consultant for Baxter Healthcare Corporation.

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 69(12)
Issue
Cleveland Clinic Journal of Medicine - 69(12)
Page Number
928-929, 933, 936, 939, 943-946
Page Number
928-929, 933, 936, 939, 943-946
Publications
Publications
Topics
Article Type
Display Headline
Emphysema in nonsmokers: Alpha 1-antitrypsin deficiency and other causes
Display Headline
Emphysema in nonsmokers: Alpha 1-antitrypsin deficiency and other causes
Sections
Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Who is conducting the deadly quartet?

Article Type
Changed
Display Headline
Who is conducting the deadly quartet?
Article PDF
Author and Disclosure Information

Brian F. Mandell, MD, PhD
Deputy Editor

Issue
Cleveland Clinic Journal of Medicine - 69(12)
Publications
Topics
Page Number
927
Sections
Author and Disclosure Information

Brian F. Mandell, MD, PhD
Deputy Editor

Author and Disclosure Information

Brian F. Mandell, MD, PhD
Deputy Editor

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 69(12)
Issue
Cleveland Clinic Journal of Medicine - 69(12)
Page Number
927
Page Number
927
Publications
Publications
Topics
Article Type
Display Headline
Who is conducting the deadly quartet?
Display Headline
Who is conducting the deadly quartet?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

The metabolic syndrome: A tug-of-war with no winner

Article Type
Changed
Display Headline
The metabolic syndrome: A tug-of-war with no winner
Article PDF
Author and Disclosure Information

Daniel J. Brotman, MD
Department of General Internal Medicine, The Cleveland Clinic

John P. Girod, DO
Department of General Internal Medicine, The Cleveland Clinic

Address: Daniel J. Brotman, MD, Department of General Internal Medicine, E13, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: brotmad@ccf.org

Issue
Cleveland Clinic Journal of Medicine - 69(12)
Publications
Topics
Page Number
990-994
Sections
Author and Disclosure Information

Daniel J. Brotman, MD
Department of General Internal Medicine, The Cleveland Clinic

John P. Girod, DO
Department of General Internal Medicine, The Cleveland Clinic

Address: Daniel J. Brotman, MD, Department of General Internal Medicine, E13, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: brotmad@ccf.org

Author and Disclosure Information

Daniel J. Brotman, MD
Department of General Internal Medicine, The Cleveland Clinic

John P. Girod, DO
Department of General Internal Medicine, The Cleveland Clinic

Address: Daniel J. Brotman, MD, Department of General Internal Medicine, E13, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: brotmad@ccf.org

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 69(12)
Issue
Cleveland Clinic Journal of Medicine - 69(12)
Page Number
990-994
Page Number
990-994
Publications
Publications
Topics
Article Type
Display Headline
The metabolic syndrome: A tug-of-war with no winner
Display Headline
The metabolic syndrome: A tug-of-war with no winner
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

A truly deadly quartet: Obesity, hypertension, hypertriglyceridemia, and hyperinsulinemia

Article Type
Changed
Display Headline
A truly deadly quartet: Obesity, hypertension, hypertriglyceridemia, and hyperinsulinemia
Article PDF
Author and Disclosure Information

Vijay Nambi, MD
Department of Internal Medicine, The Cleveland Clinic

Byron J. Hoogwerf, MD
Director, Internal Medicine Residence Program, Department of Endocrinology, The Cleveland Clinic

Dennis L. Sprecher, MD
Head, Section of Preventive Cardiology and Cardiac Rehabilitation, Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Dennis L. Sprecher, MD, Department of Cardiology, C51, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail sprechd@ccf.org

Dr. Sprecher has indicated that he has received grant or research support from the Astra/Zeneca/Merck corporation and is also on its speakers’ bureau. He also serves as a consultant for International Medical Innovations, Inc.

This paper discusses treatments that are not approved by the US Food and Drug Administration for some of the uses under discussion.

Issue
Cleveland Clinic Journal of Medicine - 69(12)
Publications
Topics
Page Number
985-989
Sections
Author and Disclosure Information

Vijay Nambi, MD
Department of Internal Medicine, The Cleveland Clinic

Byron J. Hoogwerf, MD
Director, Internal Medicine Residence Program, Department of Endocrinology, The Cleveland Clinic

Dennis L. Sprecher, MD
Head, Section of Preventive Cardiology and Cardiac Rehabilitation, Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Dennis L. Sprecher, MD, Department of Cardiology, C51, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail sprechd@ccf.org

Dr. Sprecher has indicated that he has received grant or research support from the Astra/Zeneca/Merck corporation and is also on its speakers’ bureau. He also serves as a consultant for International Medical Innovations, Inc.

This paper discusses treatments that are not approved by the US Food and Drug Administration for some of the uses under discussion.

Author and Disclosure Information

Vijay Nambi, MD
Department of Internal Medicine, The Cleveland Clinic

Byron J. Hoogwerf, MD
Director, Internal Medicine Residence Program, Department of Endocrinology, The Cleveland Clinic

Dennis L. Sprecher, MD
Head, Section of Preventive Cardiology and Cardiac Rehabilitation, Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Dennis L. Sprecher, MD, Department of Cardiology, C51, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail sprechd@ccf.org

Dr. Sprecher has indicated that he has received grant or research support from the Astra/Zeneca/Merck corporation and is also on its speakers’ bureau. He also serves as a consultant for International Medical Innovations, Inc.

This paper discusses treatments that are not approved by the US Food and Drug Administration for some of the uses under discussion.

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 69(12)
Issue
Cleveland Clinic Journal of Medicine - 69(12)
Page Number
985-989
Page Number
985-989
Publications
Publications
Topics
Article Type
Display Headline
A truly deadly quartet: Obesity, hypertension, hypertriglyceridemia, and hyperinsulinemia
Display Headline
A truly deadly quartet: Obesity, hypertension, hypertriglyceridemia, and hyperinsulinemia
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Randomized Trial Evaluating a New 0.5% Fluorouracil Formulation Demonstrates Efficacy After 1-, 2-, or 4-Week Treatment in Patients With Actinic Keratosis

Article Type
Changed
Display Headline
Randomized Trial Evaluating a New 0.5% Fluorouracil Formulation Demonstrates Efficacy After 1-, 2-, or 4-Week Treatment in Patients With Actinic Keratosis

Article PDF
Author and Disclosure Information

Jorizzo J, Stewart D, Bucko A, Davis SA, Espy P, Hino P, Rodriguez D, Savin R, Stough D, Furst K, Connolly M, Levy S

Issue
Cutis - 70(6)
Publications
Topics
Page Number
335-339
Sections
Author and Disclosure Information

Jorizzo J, Stewart D, Bucko A, Davis SA, Espy P, Hino P, Rodriguez D, Savin R, Stough D, Furst K, Connolly M, Levy S

Author and Disclosure Information

Jorizzo J, Stewart D, Bucko A, Davis SA, Espy P, Hino P, Rodriguez D, Savin R, Stough D, Furst K, Connolly M, Levy S

Article PDF
Article PDF

Issue
Cutis - 70(6)
Issue
Cutis - 70(6)
Page Number
335-339
Page Number
335-339
Publications
Publications
Topics
Article Type
Display Headline
Randomized Trial Evaluating a New 0.5% Fluorouracil Formulation Demonstrates Efficacy After 1-, 2-, or 4-Week Treatment in Patients With Actinic Keratosis
Display Headline
Randomized Trial Evaluating a New 0.5% Fluorouracil Formulation Demonstrates Efficacy After 1-, 2-, or 4-Week Treatment in Patients With Actinic Keratosis
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Coronary Artery Calcifications

Article Type
Changed
Display Headline
Coronary Artery Calcifications
Interpretation in the absence and presence of chronic renal failure
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 69(11)
Publications
Topics
Page Number
S1-S27
Sections
Article PDF
Article PDF
Interpretation in the absence and presence of chronic renal failure
Interpretation in the absence and presence of chronic renal failure
Issue
Cleveland Clinic Journal of Medicine - 69(11)
Issue
Cleveland Clinic Journal of Medicine - 69(11)
Page Number
S1-S27
Page Number
S1-S27
Publications
Publications
Topics
Article Type
Display Headline
Coronary Artery Calcifications
Display Headline
Coronary Artery Calcifications
Sections
Citation Override
Cleveland Clinic Journal of Medicine 2002 November;69(11 suppl 3):S1-S27
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Un-Gate On Date
Use ProPublica
CFC Schedule Remove Status
Hide sidebar & use full width
render the right sidebar.
Article PDF Media